moxifloxacin has been researched along with rocuronium in 2 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (rocuronium) | Trials (rocuronium) | Recent Studies (post-2010) (rocuronium) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 2,157 | 766 | 1,077 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
de Kam, PJ; Peeters, P; Prohn, M; Thomsen, T; van Kuijk, J | 1 |
1 trial(s) available for moxifloxacin and rocuronium
Article | Year |
---|---|
Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study.
Topics: Adolescent; Adult; Androstanols; Arrhythmias, Cardiac; Aza Compounds; Cross-Over Studies; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; gamma-Cyclodextrins; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Models, Biological; Moxifloxacin; Neuromuscular Nondepolarizing Agents; Quinolines; Risk Assessment; Risk Factors; Rocuronium; Sugammadex; Time Factors; Vecuronium Bromide; Young Adult | 2010 |
1 other study(ies) available for moxifloxacin and rocuronium
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |